The story of how patient advocacy, patient centric design, and partnership is rebuilding the global pharmaceutical supply chain to ensure access to all.

Speakers: 

• Laura Bray, Angels for Change, Chief Change Maker

Data analytics is playing an increasingly important role in helping companies achieve supply chain excellence. By collecting and analyzing data, companies can gain insights into their supply chains that can help them improve efficiency, reduce costs, and improve customer service. 

How Data analytics can be used to track and trace shipments, identify bottlenecks, and optimize inventory levels.

Data analytics can also be used to predict demand, forecast future trends, and identify risks.

By using data analytics, companies can make better decisions about their supply chains, which can lead to improved efficiency, reduced costs, and improved customer service.

Speakers: 

• Anthony Puleo, AstraZeneca, Associate Director, Supply Chain Data Science 

Leveraging Data Analytics for Build a More Resilient Supply Chain. Today, patients in the United States and around the world depend on medicines—and the ingredients used to make those medicines—sourced from and manufactured around the globe. The recent pandemic, geopolitical, and natural events have not only led to medicine shortages but have also exposed systemic pharmaceutical supply chain vulnerabilities. Understanding and addressing these vulnerabilities require a systematic approach to building a more resilient supply chain:

• Understanding supply chain challenges

• Implementing solutions to supply chain challenges - Detect problems and predict risk through data analytics - Provide recommendations to address and alleviate the risks - Solve problems through advanced manufacturing technologies - Scale solutions through collaborative partnerships

Speakers: 

• Matt Christian, Director, US Pharmacopeia (USP), Supply Chain Insights

Reviewing the outcome of the inflation reduction act and how it is affecting pharmaceutical manufacturers and distributors in managing drug pricing within the supply chain, including examining broader economic and market trends influencing drug pricing within the supply chain economy and their effects across US Healthcare.

Speakers: 

• Joanne Chan, Pharmaceutical Research and Manufacturers of America (PhRMA), Senior Assistance General Counsel /Head of State Legal
• John Murphy, BIO, Chief Policy Officer

Join us as our experts delve into the current state of pharmaceutical manufacturing on American soil, examining the drivers, challenges, and outcomes of the onshoring trend within the US pharma industry.

• Examining case studies and success stories that highlight the progress and challenges in realizing onshoring goals within the US pharma market 
• Analyzing the impact of regulatory changes and supply chain disruptions on onshoring efforts 
• Assessing hybrid Onshoring and Nearshoring

Speakers:

• Bikash Chatterjee, Pharmatech Associates - a USP company, President, chief science officer
• Dr. Rob York, Pacific Forum, Director for Regional Affairs
  
• Andrew Gonce, Mallinckrodt Specialty Generics, VP, Commercial & Strategy
• Christina Smolke, Antheia, CEO and co-founder
• Kevin Webb, API Innovation Center, Chief Operating Officer